Ligands with its PDB code and its tanimoto calculated from the molecule, present in the database, which has for MMscode: MMs02501512
You can sort the columns by Ligand, Ligand name, PDB and Tanimoto.
You can sort the columns by Ligand, Ligand name, PDB and Tanimoto.
Ligand | Ligand name | Chain | PDB | Tanimoto | Ligand in PDB |
---|---|---|---|---|---|
Ligand | Ligand name | Chain | PDB | Tanimoto | Ligand in PDB |
GDM | GELDANAMYCIN | A | 1YET | 0.72 | |
BID | BISTRAMIDE A | A | 2FXU | 0.72 | |
FK5 | 8-DEETHYL-8-[BUT-3-ENYL]-ASCOMYCIN | A | 2FKE | 0.75 | |
FK5 | 8-DEETHYL-8-[BUT-3-ENYL]-ASCOMYCIN | A | 1FKF | 0.75 | |
FK5 | 8-DEETHYL-8-[BUT-3-ENYL]-ASCOMYCIN | A,B,C | 1TCO | 0.75 | |
FK5 | 8-DEETHYL-8-[BUT-3-ENYL]-ASCOMYCIN | A,B | 1Q6I | 0.75 | |
FK5 | 8-DEETHYL-8-[BUT-3-ENYL]-ASCOMYCIN | A | 1FKJ | 0.75 | |
FK5 | 8-DEETHYL-8-[BUT-3-ENYL]-ASCOMYCIN | A,B | 2VN1 | 0.75 | |
FK5 | 8-DEETHYL-8-[BUT-3-ENYL]-ASCOMYCIN | A | 1YAT | 0.75 | |
FK5 | 8-DEETHYL-8-[BUT-3-ENYL]-ASCOMYCIN | A | 1BKF | 0.75 | |
KOS | 17-DESMETHOXY-17-N,N-DIMETHYLAMINOETHYLAMINO- GELDANAMYCIN | A | 1OSF | 0.78 | |
CNP | 2-PROPENYL-N-ACETYL-NEURAMIC ACID | A | 4SLI | 0.71 | |
IGC | N-[(1S,2R,3E)-1-({[ALPHA-D-GALACTOPYRANOSYL- (1->3)-BETA-D-GALACTOPYRANOSYL- (1->4)-BETA-D-GLUCOPYRANOSYL]OXY}METHYL)- 2-HYDROXYHEPTADEC-3-EN-1-YL]OCTANAMIDE | A,C | 2Q7Y | 0.7 | |
RAD | C49-METHYL RAPAMYCIN | A | 2FAP | 0.76 | |
RAD | C49-METHYL RAPAMYCIN | A | 1NSG | 0.76 | |
818 | 18-HYDROXYASCOMYCIN | A | 1FKD | 0.75 | |
STD | STREPTOLYDIGIN | D,M,N | 1ZYR | 0.71 | |
STD | STREPTOLYDIGIN | D,N | 2A6H | 0.71 | |
STD | STREPTOLYDIGIN | D,M,N | 2PPB | 0.71 | |
GMY | GELDANAMYCIN | A | 2ESA | 0.72 | |
GMY | GELDANAMYCIN | A | 2WEQ | 0.72 | |
GMY | GELDANAMYCIN | A,B | 2EXL | 0.72 | |
GMY | GELDANAMYCIN | A | 1A4H | 0.72 | |
GMY | GELDANAMYCIN | A | 3C11 | 0.72 | |
G39 | 5-N-ACETYL-3-(1-ETHYLPROPYL)-1- CYCLOHEXENE-1-CARBOXYLIC ACID | A | 2QWH | 0.71 | |
G39 | 5-N-ACETYL-3-(1-ETHYLPROPYL)-1- CYCLOHEXENE-1-CARBOXYLIC ACID | A | 3CL0 | 0.71 | |
G39 | 5-N-ACETYL-3-(1-ETHYLPROPYL)-1- CYCLOHEXENE-1-CARBOXYLIC ACID | A | 2QWK | 0.71 | |
G39 | 5-N-ACETYL-3-(1-ETHYLPROPYL)-1- CYCLOHEXENE-1-CARBOXYLIC ACID | A,B,C,D,E,F, G,H | 3CL2 | 0.71 | |
G39 | 5-N-ACETYL-3-(1-ETHYLPROPYL)-1- CYCLOHEXENE-1-CARBOXYLIC ACID | A | 2HT8 | 0.71 | |
G39 | 5-N-ACETYL-3-(1-ETHYLPROPYL)-1- CYCLOHEXENE-1-CARBOXYLIC ACID | A | 2HT7 | 0.71 | |
G39 | 5-N-ACETYL-3-(1-ETHYLPROPYL)-1- CYCLOHEXENE-1-CARBOXYLIC ACID | B | 2HU0 | 0.71 | |
G39 | 5-N-ACETYL-3-(1-ETHYLPROPYL)-1- CYCLOHEXENE-1-CARBOXYLIC ACID | A,B,C,D,E,F, G,H | 2HU4 | 0.71 | |
RAP | RAPAMYCIN IMMUNOSUPPRESSANT DRUG | A | 2DG3 | 0.76 | |
RAP | RAPAMYCIN IMMUNOSUPPRESSANT DRUG | A | 1PBK | 0.76 | |
RAP | RAPAMYCIN IMMUNOSUPPRESSANT DRUG | 2 | 1Z58 | 0.76 | |
RAP | RAPAMYCIN IMMUNOSUPPRESSANT DRUG | A | 2DG9 | 0.76 | |
RAP | RAPAMYCIN IMMUNOSUPPRESSANT DRUG | A | 1C9H | 0.76 | |
RAP | RAPAMYCIN IMMUNOSUPPRESSANT DRUG | A | 1FKB | 0.76 | |
RAP | RAPAMYCIN IMMUNOSUPPRESSANT DRUG | A | 1FAP | 0.76 | |
RAP | RAPAMYCIN IMMUNOSUPPRESSANT DRUG | A | 1FKL | 0.76 | |
RAP | RAPAMYCIN IMMUNOSUPPRESSANT DRUG | A | 2DG4 | 0.76 | |
RAP | RAPAMYCIN IMMUNOSUPPRESSANT DRUG | A | 2VCD | 0.76 | |
CYV | ETHYL (4R)-4-{[(2R,5S)-5-{[N-(TERT- BUTOXYCARBONYL)-L-SERYL]AMINO}- 6-METHYL-2-(3-METHYLBUT-2-EN-1- YL)-4-OXOHEPTANOYL]AMINO}-5-[(3R)- 2-OXOPYRROLIDIN-3-YL]PENTANOATE | A | 2QIQ | 0.7 | |
KIR | KIRROMYCIN | A,B | 1OB2 | 0.7 |